So, Palantir Technologies (PLTR) is having a bit of a sleepy Tuesday morning. The stock is ticking lower in premarket trading, which might seem odd given the company just landed what looks like a pretty big deal with the Pentagon. But that's the market for you—sometimes the big picture news gets drowned out by the daily noise of futures and sector rotations.
Right now, that noise is a bit defensive. Nasdaq futures are down 0.22%, S&P 500 futures are off 0.25%, and the technology sector is fractionally lower. When the tide goes out like this, it often pulls down high-flying, high-valuation names like Palantir, even if their own story is intact. It's less about Palantir specifically and more about the mood in the room.
This softness follows a rally yesterday, which was fueled by a mix of geopolitical relief and, yes, that military contract news. The broader market breathed a sigh of relief after former President Donald Trump signaled a five-day pause on planned U.S. strikes, describing discussions with Iranian officials as "very good and productive" on Truth Social. That helped ease tensions after a weekend ultimatum regarding the Strait of Hormuz.
And then there's the real meat for Palantir: Reuters reported last Friday that the Pentagon will formally adopt Palantir's Maven Smart System. Deputy Secretary of Defense Steve Feinberg issued the directive back on March 9. This isn't just a pilot program or a test—it's the kind of move that locks in long-term funding for an AI-powered weapons-targeting platform. In the world of government contracts, that's the golden ticket.
Technical Analysis
Let's look under the hood. Technically, Palantir is sending some mixed signals, which might explain why it's not shooting straight up on the contract news. The stock is trading 7.2% above its 20-day simple moving average (SMA), which suggests some short-term strength. But it's also 3.6% below its 100-day SMA, indicating there's a longer-term ceiling overhead that it hasn't quite broken through yet.
Over the past 12 months, shares are up a whopping 66.24%, and they're positioned much closer to their 52-week highs than their lows. The Relative Strength Index (RSI) is at 60.70, which sits in neutral territory—it suggests positive momentum but nothing that's stretched into overbought panic-buying territory. Meanwhile, the MACD is bullish, with the MACD line at 2.3523 sitting above the signal line at 1.1032. That keeps the near-term trend biased upward, even with this premarket dip.
So, you've got neutral RSI and bullish MACD: mixed momentum. For the chart watchers, key resistance sits at $161.50, and key support is down at $148.00.
Palantir Earnings & Analyst Outlook
Looking further out, the next major scheduled catalyst for the stock is the estimated earnings report on May 4, 2026. The expectations are steep: analysts are looking for earnings per share (EPS) of 26 cents, which would be up from 13 cents year-over-year. Revenue is estimated at $1.54 billion, a significant jump from $880 million YoY.
Of course, with those growth expectations comes a premium price tag. The stock trades at a P/E ratio of 255.3x, which is... not cheap. It's the kind of multiple you pay when you're betting on massive future expansion, not current profits.
And analysts are largely making that bet. The consensus rating on the stock is a Buy, with an average price target of $196.43. Recent moves have been bullish:
- UBS: Buy rating, raising its target price to $200.00 (March 18).
- Wedbush: Outperform rating, maintaining its target at $230.00 (March 16).
- Rosenblatt: Buy rating, raising its target to $200.00 (March 3).
